Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Sharon, Micallef"'
Autor:
Simon Finfer, Sharon Micallef
Publikováno v:
Critical Care and Resuscitation. 24:242-250
OBJECTIVE: Pregnancy is a risk factor for acute respiratory failure (ARF) following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We hypothesised that SARS-CoV-2 viral load in the respiratory tract might be higher in pregnan
Autor:
Anders Granholm, Sharon Micallef, Naomi Hammond, Bala Venkatesh, Bharath Kumar Tirupakuzhi Vijayaraghavan
BackgroundThe COVID-STEROID 2 trial found high probability of benefit with dexamethasone 12 mg vs. 6 mg daily among patients with COVID-19 and severe hypoxemia. There was suggestion of heterogeneity of treatment effects (HTE)between patients enrolled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::002ee718e7f857d2e4ebdefe614eef6a
https://doi.org/10.1101/2022.11.23.22282463
https://doi.org/10.1101/2022.11.23.22282463
Autor:
Fernando G Zampieri, Alexandre B Cavalcanti, Gian Luca Di Tanna, Lucas P Damiani, Naomi E Hammond, Flavia R Machado, Sharon Micallef, John Myburgh, Mahesh Ramanan, Todd W Rice, Matthew W Semler, Paul J Young, Simon Finfer
PurposeThe Balanced versus Saline Trialists (BEST) -Living Study is an ongoing living systematic review with aggregated and individual patient data meta-analysis (IPDMA) from eligible trials that assessed the effects of using balanced solutions compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9c2185c6b28e7dc84eb3e0f89d5b9ad
https://doi.org/10.1101/2022.09.06.22279363
https://doi.org/10.1101/2022.09.06.22279363
Autor:
Sharon Micallef, Colman Taylor, Naomi E Hammond, Diane Mackle, Rinaldo Bellomo, David Gattas, Martin Gallagher, Leanlove Navarra, Manoj Saxena, Laurent Billot, Paul J Young, John Myburgh, Simon Finfer, Renal
Publikováno v:
Critical Care and Resuscitation. 23:24-31
Background and objective: The Plasma-Lyte 148 versus Saline (PLUS) study is a prospective, multicentre, parallel-group, concealed, blinded, randomised controlled trial comparing the effect of Plasma-Lyte 148 versus 0.9% sodium chloride (saline) for f
Autor:
Naomi E. Hammond, Fernando G. Zampieri, Gian Luca Di Tanna, Tessa Garside, Derick Adigbli, Alexandre B. Cavalcanti, Flavia R. Machado, Sharon Micallef, John Myburgh, Mahesh Ramanan, Todd W. Rice, Matthew W. Semler, Paul J. Young, Balasubramanian Venkatesh, Simon Finfer, Anthony Delaney
Publikováno v:
NEJM Evidence. 1
Autor:
Simon, Finfer, Sharon, Micallef, Naomi, Hammond, Leanlove, Navarra, Rinaldo, Bellomo, Laurent, Billot, Anthony, Delaney, Martin, Gallagher, David, Gattas, Qiang, Li, Diane, Mackle, Jayanthi, Mysore, Manoj, Saxena, Colman, Taylor, Paul, Young, John, Myburgh, Mary, La Pine
Publikováno v:
The New England journal of medicine. 386(9)
Whether the use of balanced multielectrolyte solution (BMES) in preference to 0.9% sodium chloride solution (saline) in critically ill patients reduces the risk of acute kidney injury or death is uncertain.In a double-blind, randomized, controlled tr
Autor:
Anders Granholm, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, Sheila Nainan Myatra, Bharath Kumar Tirupakuzhi Vijayaraghavan, Maria Cronhjort, Rebecka Rubenson Wahlin, Stephan M. Jakob, Luca Cioccari, Gitte Kingo Vesterlund, Tine Sylvest Meyhoff, Marie Helleberg, Morten Hylander Møller, Thomas Benfield, Balasubramanian Venkatesh, Naomi E. Hammond, Sharon Micallef, Abhinav Bassi, Oommen John, Vivekanand Jha, Klaus Tjelle Kristiansen, Charlotte Suppli Ulrik, Vibeke Lind Jørgensen, Margit Smitt, Morten H. Bestle, Anne Sofie Andreasen, Lone Musaeus Poulsen, Bodil Steen Rasmussen, Anne Craveiro Brøchner, Thomas Strøm, Anders Møller, Mohd Saif Khan, Ajay Padmanaban, Jigeeshu Vasishtha Divatia, Sanjith Saseedharan, Kapil Borawake, Farhad Kapadia, Subhal Dixit, Rajesh Chawla, Urvi Shukla, Pravin Amin, Michelle S. Chew, Christian Aage Wamberg, Neeta Bose, Mehul S. Shah, Iben S. Darfelt, Christian Gluud, Theis Lange, Anders Perner
Publikováno v:
Granholm, A, Kjær, M-B N, Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Cronhjort, M, Wahlin, R R, Jakob, S M, Cioccari, L, Vesterlund, G K, Meyhoff, T S, Helleberg, M, Møller, M H, Benfield, T, Venkatesh, B, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, V, Kristiansen, K T, Ulrik, C S, Jørgensen, V L, Smitt, M, Bestle, M H, Andreasen, A S, Poulsen, L M, Rasmussen, B S, Brøchner, A C, Strøm, T, Møller, A, Khan, M S, Padmanaban, A, Divatia, J V, Saseedharan, S, Borawake, K, Kapadia, F, Dixit, S, Chawla, R, Shukla, U, Amin, P, Chew, M S, Wamberg, C A, Bose, N, Shah, M S, Darfelt, I S, Gluud, C, Lange, T & Perner, A 2022, ' Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia ', Intensive Care Medicine, vol. 48, no. 5, pp. 580–589 . https://doi.org/10.1007/s00134-022-06677-2
Granholm, A, Kjær, M B N, Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Cronhjort, M, Wahlin, R R, Jakob, S M, Cioccari, L, Vesterlund, G K, Meyhoff, T S, Helleberg, M, Møller, M H, Benfield, T, Venkatesh, B, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, V, Kristiansen, K T, Ulrik, C S, Jørgensen, V L, Smitt, M, Bestle, M H, Andreasen, A S, Poulsen, L M, Rasmussen, B S, Brøchner, A C, Strøm, T, Møller, A, Khan, M S, Padmanaban, A, Divatia, J V, Saseedharan, S, Borawake, K, Kapadia, F, Dixit, S, Chawla, R, Shukla, U, Amin, P, Chew, M S, Wamberg, C A, Bose, N, Shah, M S, Darfelt, I S, Gluud, C, Lange, T & Perner, A 2022, ' Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia ', Intensive Care Medicine, vol. 48, no. 5, pp. 580-589 . https://doi.org/10.1007/s00134-022-06677-2
Granholm, A, Kjær, M-B N, Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Cronhjort, M, Wahlin, R R, Jakob, S M, Cioccari, L, Vesterlund, G K, Meyhoff, T S, Helleberg, M, Møller, M H, Benfield, T, Venkatesh, B, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, V, Kristiansen, K T, Ulrik, C S, Jørgensen, V L, Smitt, M, Bestle, M H, Andreasen, A S, Poulsen, L M, Rasmussen, B S, Brøchner, A C, Strøm, T, Khan, M S, Padmanaban, A, Divatia, J V, Saseedharan, S, Borawake, K, Kapadia, F, Dixit, S, Chawla, R, Shukla, U, Amin, P, Chew, M S, Wamberg, C A, Bose, N, Shah, M S, Darfelt, I S, Gluud, C, Lange, T & Perner, A 2022, ' Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia ', Intensive Care Medicine, vol. 48, no. 5, pp. 580-589 . https://doi.org/10.1007/s00134-022-06677-2
Granholm, A, Kjær, M B N, Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Cronhjort, M, Wahlin, R R, Jakob, S M, Cioccari, L, Vesterlund, G K, Meyhoff, T S, Helleberg, M, Møller, M H, Benfield, T, Venkatesh, B, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, V, Kristiansen, K T, Ulrik, C S, Jørgensen, V L, Smitt, M, Bestle, M H, Andreasen, A S, Poulsen, L M, Rasmussen, B S, Brøchner, A C, Strøm, T, Møller, A, Khan, M S, Padmanaban, A, Divatia, J V, Saseedharan, S, Borawake, K, Kapadia, F, Dixit, S, Chawla, R, Shukla, U, Amin, P, Chew, M S, Wamberg, C A, Bose, N, Shah, M S, Darfelt, I S, Gluud, C, Lange, T & Perner, A 2022, ' Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia ', Intensive Care Medicine, vol. 48, no. 5, pp. 580-589 . https://doi.org/10.1007/s00134-022-06677-2
Granholm, A, Kjær, M-B N, Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Cronhjort, M, Wahlin, R R, Jakob, S M, Cioccari, L, Vesterlund, G K, Meyhoff, T S, Helleberg, M, Møller, M H, Benfield, T, Venkatesh, B, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, V, Kristiansen, K T, Ulrik, C S, Jørgensen, V L, Smitt, M, Bestle, M H, Andreasen, A S, Poulsen, L M, Rasmussen, B S, Brøchner, A C, Strøm, T, Khan, M S, Padmanaban, A, Divatia, J V, Saseedharan, S, Borawake, K, Kapadia, F, Dixit, S, Chawla, R, Shukla, U, Amin, P, Chew, M S, Wamberg, C A, Bose, N, Shah, M S, Darfelt, I S, Gluud, C, Lange, T & Perner, A 2022, ' Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia ', Intensive Care Medicine, vol. 48, no. 5, pp. 580-589 . https://doi.org/10.1007/s00134-022-06677-2
PURPOSE: We assessed long-term outcomes of dexamethasone 12 mg versus 6 mg given daily for up to 10 days in patients with coronavirus disease 2019 (COVID-19) and severe hypoxaemia.METHODS: We assessed 180-day mortality and health-related quality of l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a03aca1ede6095b26a7bc6659898e2a
Autor:
John A, Myburgh, Ian M, Seppelt, Fiona, Goodman, Laurent, Billot, Maryam, Correa, Joshua S, Davis, Anthony C, Gordon, Naomi E, Hammond, Jon, Iredell, Qiang, Li, Sharon, Micallef, Jennene, Miller, Jayanthi, Mysore, Colman, Taylor, Paul J, Young, Brian H, Cuthbertson, Michael, Tattersall
Publikováno v:
JAMA
ImportanceWhether selective decontamination of the digestive tract (SDD) reduces mortality in critically ill patients remains uncertain.ObjectiveTo determine whether SDD reduces in-hospital mortality in critically ill adults.Design, Setting, and Part
Autor:
Mahesh Ramanan, Sharon Micallef, Naomi E Hammond, Paul J Young, Matthew W. Semler, Balasubramanian Venkatesh, Gian Luca Di Tanna, Flávia Ribeiro Machado, Alexandre Biasi Cavalcanti, Simon Finfer, Anthony Delaney, Derek Adigbli, John Myburgh, Todd W. Rice, Fernando G. Zampieri, Tessa Garside
IntroductionThe choice of intravenous fluid for fluid therapy in critically ill adult patients remains a matter of debate. Currently, crystalloids are used more often than colloids, with ongoing controversy over the relative efficacy and safety of bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::855efee0380bb37be4c119d4c38b54b2
https://doi.org/10.1101/2021.08.24.21262515
https://doi.org/10.1101/2021.08.24.21262515
Autor:
MARIE HELLEBERG, Sharon Micallef, Christian Gluud, Rebecka Rubenson Wahlin, Vivekanand Jha, URVI SHUKLA, Camilla Meno Kristensen, Anders Perner
IMPORTANCEDexamethasone 6 mg daily is recommended for up to 10 days in patients with severe and critical COVID-19, but a higher dose may benefit those with more severe disease.OBJECTIVETo assess the effects of dexamethasone 12 mg versus 6 mg daily in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c190ac302b0be98fb3e5f4bcca3bf779
https://doi.org/10.1101/2021.07.22.21260755
https://doi.org/10.1101/2021.07.22.21260755